van Bragt JJMH, de Vries R, Sterk PJ, Maitland-van der Zee AH. Exhaled breath analysis for prediction of responders to mepolizumab in patients with severe asthma. Am J Resp Crit Care Med. 2019;199:A2673.
FLAURA2 toont overlevingsvoordeel van osimertinib plus chemotherapie
dec 2025 | Longoncologie